Skip to main content
Filing year 2023

INTERNATIONAL NETWORK FOR CANCER TREATMENT AND RES

Dallas, Texas·EIN 54-1949079·NTEE H30 · Medical Research·501(c)(3)
Total revenue
$1k
Total assets
$8k
Total expenses
$261
Reported officers
1

Reported officers (all unpaid)

No paid executives reported in 2023. INTERNATIONAL NETWORK FOR CANCER TREATMENT AND RES reported 1 unpaid officer or board member on its 990-PF.

President & CEO

Grants paid

Itemized grants reported on this foundation's 2023 Form 990-PF, Part XV.

Total granted

$0

Itemized grants

0

This is a private foundation. Peers are foundations of similar asset size (Under $1M), because foundation pay scales with assets under management, not revenue.

Sector benchmark

What Medical Research executives earn in Texas

INTERNATIONAL NETWORK FOR CANCER TREATMENT AND RES reported no executive compensation in its latest filing. For context, the highest-paid executive at a comparable medical research organization in Texas earns a median of $99,999.

25th percentile
$50k
Median
$99,999
75th percentile
$225k
90th percentile
$412k

These are medical research sector-wide figures, not this organization's reported pay. Based on 63 organizations across 63 filings (2023 – 2024).

See full Medical Research pay data for Texas
FAQ

Common questions about INTERNATIONAL NETWORK FOR CANCER TREATMENT AND RES

What are INTERNATIONAL NETWORK FOR CANCER TREATMENT AND RES's revenue and expenses?

In 2023, INTERNATIONAL NETWORK FOR CANCER TREATMENT AND RES reported $1k in total revenue and $261 in total expenses on its IRS Form 990.

Free, forever
Build lists. Save your benchmarks.
A free Lucido account lets you build lists of nonprofits and save your search filters. No credit card.
Already a member? Sign in
Build a benchmark

Compare any role, sector, or revenue band

Build your own benchmark from millions of reported positions.

This is a private foundation. Peers are foundations of similar asset size (Under $1M), because foundation pay scales with assets under management, not revenue.